Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 22 most recent Form 4 transactions.
| $892.1K |
| -15.9% |
| Open the original filing on SEC.gov |
| Aug 3 | TEVA | Teva Pharmaceutical… | MEXER◷ | 52,744 | — | — | +49.0% | Open the original filing on SEC.gov |
| Jun 11 | GLUE | Monte Rosa Therapeutics,… | AGRANT◆ | 25,800 | — | — | — | Open the original filing on SEC.gov |
| Mar 5 | TEVA | Teva Pharmaceutical… | MEXER◷◆ | 19,654 | — | — | — | Open the original filing on SEC.gov |
| Mar 5 | TEVA | Teva Pharmaceutical… | SSELL◷ | 9,533 | $31.67 | $301.9K | -8.1% | Open the original filing on SEC.gov |
| Mar 5 | TEVA | Teva Pharmaceutical… | MEXER◷ | 19,654 | — | — | +20.1% | Open the original filing on SEC.gov |
| Mar 4 | TEVA | Teva Pharmaceutical… | AGRANT◷◆ | 50,643 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | TEVA | Teva Pharmaceutical… | MEXER◷◆ | 23,251 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | TEVA | Teva Pharmaceutical… | SSELL◷ | 11,277 | $32.46 | $366.1K | -10.4% | Open the original filing on SEC.gov |
| Mar 4 | TEVA | Teva Pharmaceutical… | MEXER◷ | 23,251 | — | — | +27.2% | Open the original filing on SEC.gov |
| Mar 3 | TEVA | Teva Pharmaceutical… | MEXER◷◆ | 141,478 | — | — | — | Open the original filing on SEC.gov |
| Mar 3 | TEVA | Teva Pharmaceutical… | MEXER◷◆ | 24,900 | — | — | — | Open the original filing on SEC.gov |
| Mar 3 | TEVA | Teva Pharmaceutical… | SSELL◷ | 68,685 | $32.36 | $2.2M | -44.5% | Open the original filing on SEC.gov |
| Mar 3 | TEVA | Teva Pharmaceutical… | MEXER◷ | 141,478 | — | — | +1,103% | Open the original filing on SEC.gov |
| Mar 3 | TEVA | Teva Pharmaceutical… | SSELL◷ | 12,077 | $32.36 | $390.8K | -48.5% | Open the original filing on SEC.gov |
| Mar 3 | TEVA | Teva Pharmaceutical… | MEXER◷ | 24,900 | — | — | — | Open the original filing on SEC.gov |
| Jan 27 | TEVA | Teva Pharmaceutical… | AGRANT◆ | 141,478 | — | — | — | Open the original filing on SEC.gov |
| Aug 1, 2025 | TEVA | Teva Pharmaceutical… | MEXER◷◆ | 52,742 | — | — | — | Open the original filing on SEC.gov |
| Aug 1, 2025 | TEVA | Teva Pharmaceutical… | SSELL◷ | 52,742 | $15.16 | $799.4K | -100.0% | Open the original filing on SEC.gov |
| Aug 1, 2025 | TEVA | Teva Pharmaceutical… | MEXER◷ | 52,742 | — | — | — | Open the original filing on SEC.gov |
| Jun 13, 2025 | GLUE | Monte Rosa Therapeutics,… | AGRANT◆ | 30,700 | — | — | — | Open the original filing on SEC.gov |